| Literature DB >> 34310223 |
Anamarija Habič1,2, Metka Novak1, Bernarda Majc1,2, Tamara Lah Turnšek1,2,3, Barbara Breznik1.
Abstract
Proteolytic activity is perturbed in tumors and their microenvironment, and proteases also affect cancer stem cells (CSCs). CSCs are the therapy-resistant subpopulation of cancer cells with tumor-initiating capacity that reside in specialized tumor microenvironment niches. In this review, we briefly summarize the significance of proteases in regulating CSC activities with a focus on brain tumor glioblastoma. A plethora of proteases and their inhibitors participate in CSC invasiveness and affect intercellular interactions, enhancing CSC immune, irradiation, and chemotherapy resilience. Apart from their role in degrading the extracellular matrix enabling CSC migration in and out of their niches, we review the ability of proteases to modulate CSC properties, which prevents their elimination. When designing protease-oriented therapies, the multifaceted roles of proteases should be thoroughly investigated.Entities:
Keywords: angiogenesis; cancer; cancer stem cells; epithelial-to-mesenchymal transition; glioblastoma; invasion; proteases; stemness; tissue niches; tumor heterogeneity; tumor immune infiltrate; tumor microenvironment
Mesh:
Substances:
Year: 2021 PMID: 34310223 PMCID: PMC8647633 DOI: 10.1369/00221554211035192
Source DB: PubMed Journal: J Histochem Cytochem ISSN: 0022-1554 Impact factor: 2.479